The QualityStocks Daily Wednesday, June 27th, 2018

Today's Top 3 Investment Newsletters

MarketBeat (PED) +659.62%

BUYINS.NET (DFBG) +512.36%

QualityStocks (ITLL) +90.48%

The QualityStocks Daily Stock List

AXIM Biotechnologies, Inc. (AXIM)

TopPennyStockMovers, CFN Media Group, Promotion Stock Secrets, and SmallCapVoice reported earlier on AXIM Biotechnologies, Inc. (AXIM), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

AXIM Biotechnologies, Inc. is a biotechnology company focusing on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. The OTCQB-listed Company discovers and brings to market inventive solutions through research and development (R&D), strategic partnerships, and acquisitions through setting the green standard in the industrial hemp industry. AXIM Biotechnologies has its head office in New York, New York. Medical Marijuana, Inc. (MJNA) is a major investor in AXIM.

AXIM Biotechnologies’ focus is on unique, proprietary delivery mechanisms for the introduction of cannabinoids and finding solutions for conditions for which there is presently no effective treatment. The Company is advancing its patented controlled-release cannabinoid gum in studies covering a number of indications.

AXIM’s IP portfolio now includes two fully issued patents – one patent permitting the use of CBD (cannabidiol) in controlled-release, functional chewing gum, and another patent for chewing gum containing natural and synthetic cannabinoids for the treatment of pain, and 15 patent applications in varying stages of approval.

AXIM’s flagship CanChew Plus® contains 10mg of cannabidiol (CBD) obtained from industrial hemp plants. In addition, the Company has its CanChew+ 50®. This product contains 50 mg of CBD. CanChew+ 50®is undergoing clinical trials in patients with IBS (Irritable Bowel Syndrome).

AXIM Biotechnologies’ pipeline of Intellectual Property (IP) protected cannabinoid-based products also includes MedChew Rx™. This THC/CBD cannabinoid controlled-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients. It is the world’s first patented cannabinoid controlled-release chewing gum.

Medical Marijuana, Inc. (MJNA) announced this past February that its major investment company AXIM Biotechnologies successfully executed its first-ever proprietary current good manufacturing practices (cGMP) methodology in the extraction and microencapsulation of cannabinoid molecules for a variety of pharmaceutical delivery formats from cGMP-produced medicinal cannabis.

This breakthrough makes AXIM Biotechnologies the only Company worldwide with the ability to harness the proprietary procedure and provide Active Pharmaceutical Ingredients (APIs) of such purity from naturally extracted cGMP sources.

Recently, AXIM Biotechnologies announced that the European Patent Office (EPO) published a patent application owned by AXIM for an invention entitled “Anti-Microbial Composition Comprising Cannabinoids,” EU Patent Publication Number 16815133.0. This patent application relates to the formulation of cannabinoid-based products using different delivery methods including spray, cream, liquid, and powder form. The patent application covers numerous cannabinoids.

In May, AXIM Biotechnologies announced that it reached a long-term purchase agreement for pharmaceutical-grade dronabinol with Noramco. The agreement outlines an initial purchase of the Active Pharmaceutical Ingredient (API) dronabinol, which is a synthetic form of tetrahydrocannabinol (THC), to be used in AXIM Biotechnologies’ clinical trials for the treatment of chemotherapy-induced nausea/vomiting (CINV) and anorexia associated with weight loss in patients with cancer or AIDS. Noramco is an international leader in the production of controlled substances for the pharmaceutical industry.

AXIM will microencapsulate the API. It will formulate it into its proprietary controlled-release chewing gum delivery system that will go through an open-label clinical study comparing the bioavailability and therapeutic equivalence of AXIM’s product to the Food and Drug Administration (FDA)-approved reference listed drug (RLD) Marinol®.

Last week, AXIM Biotechnologies announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Application Serial Number 15/146,668, a patent on a methodology developed by AXIM for extraction and purification of the cannabinoid molecule delta-9-tetrahydrocannabinol (THC). A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from the Company’s patent application, filed in May of 2015.

AXIM Biotechnologies, Inc. (AXIM), closed Wednesday's trading session at $2.67, up 11.25%, on 83,578 volume with 238 trades. The average volume for the last 60 days is 52,059 and the stock's 52-week low/high is $2.28/$11.30.


FieldPoint Petroleum Corp. (FPPP)

Stock Twits, InvestorsHub, OTC Markets, Equity Clock, MarketWatch, and The Street reported on FieldPoint Petroleum Corp. (FPPP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

FieldPoint Petroleum Corp. engages in the acquisition, development, and operation of oil and natural gas properties in the U.S. The Company engages in oil and natural gas exploration, production, and acquisition, primarily in Louisiana, New Mexico, Oklahoma, Texas, and Wyoming. FieldPoint Petroleum has its head office in Austin, Texas. The Company lists on the OTCQB.

At present, the Company has varying ownership interests in 480 gross producing wells (96 net) in the above-mentioned States. FieldPoint Petroleum’s strategy focuses on expanding its reserve base. This is while increasing production and cash flow via the acquisition of leasehold interests and producing oil and gas wells.

More recently, FieldPoint Petroleum has chosen to concentrate on promising areas for oil & gas exploration. These areas include the Lusk Field in Lea County, New Mexico, and the Company’s Ranger Project in the Taylor Serbin Field near Giddings, Texas.

In projects like these, FieldPoint Petroleum partners with enterprises that complement internal expertise in evaluate opportunities and in making investment decisions. Concerning producing oil & gas properties, the Company operates 19 wells. Independent contractors operate the other wells per standard industry contracts.

Pertaining to operated wells, FieldPoint Petroleum’s portfolio includes chiefly low-touch, “pumper and electricity-only” wells in the Devonian, Ellenberger, and Morrow areas of West Texas and New Mexico. Higher maintenance fields are closer to home. These include the Taylor Serbin field close to Giddings, Texas. Most of FieldPoint’s production comes from its East Lusk and Serbin Fields.

In Texas, FieldPoint Petroleum is active in Andrews County, Midland County, and Lee & Bastrop Counties. In Louisiana, FieldPoint is active in Caddo Parrish. In Oklahoma, it is active in Grady County and Pontotoc County.

In Wyoming, the Company is active in Converse County and Campbell County. FieldPoint Petroleum is active in Lea County, Chaves County, and Eddy County in New Mexico.

In May, FieldPoint Petroleum announced financial results for its Q1 ended March 31, 2018. Revenues decreased to $492,962 from $838,426. The Company’s Net Loss decreased to ($210,773) from ($409,051). Net Loss per Share decreased - basic to ($0.02) from ($0.04) and fully diluted to ($0.02) from ($0.04).

Mr. Phillip Roberson, FieldPoint Petroleum President and Chief Financial Officer, said, "After this long period of depressed commodity pricing, we are finally seeing some relief. Pricing toward the end of our first quarter reached a manageable level, and if this recovery is sustainable, we expect to be able to further reduce our debt and return to our plan of growth for the company in the near term…”

FieldPoint Petroleum Corp. (FPPP), closed Wednesday's trading session at $0.19, up 26.67%, on 118,241 volume with 24 trades. The average volume for the last 60 days is 15,213 and the stock's 52-week low/high is $0.10/$0.20.


Cornerstone Metals, Inc. (CCCCF)

StockPulse, Penny Stock Hub, Stockwatch, Market News Updates, Stockhouse, Geology for Investors, Business Insider, MarketWatch, The Prospector News, OTC Markets, Morningstar, TradingView, Metals Channel, Barchart, Market Trend News, 4-Traders, Investors Hangout, Wallmine, and 24hgold reported on Cornerstone Metals, Inc. (CCCCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cornerstone Metals, Inc. engages in the acquisition, exploration, and development of mineral properties in the U.S. and Canada. The Company’s Carlin Vanadium Project hosts one of North America’s largest, richest, primary Vanadium deposits, located in Nevada. Its West Jerome project targets a large scale high grade copper and zinc deposit in Arizona. Cornerstone Metals is headquartered in Vancouver, British Columbia. The Company lists on the OTC Markets’ OTCQB.

Cornerstone Metals has an option to earn a 100 percent interest in the Carlin Vanadium Project situated in Elko County, 14 miles from the town of Carlin, Nevada. The project consists of 72 contiguous unpatented mineral claims totaling 461 hectares (1,140 acres).

The Carlin Vanadium deposit was discovered by Union Carbide Corp. in the 1960’s, completing 127 rotary drill holes systematically defining near surface shallow dipping deposit. Carlin is a major rail hub to the East and West Coasts.

The Carlin Vanadium Project hosts the Carlin Vanadium Deposit that is flat to shallow dipping and at shallow depths, usually between 0-60m (0-200 ft) below surface. Cornerstone Metals is fast tracking this project. The Company is aiming for a one year timeline from “rediscovery” to Indicated Resource, to quickly unlock potential project value.

Cornerstone Metals also has its West Jerome Project. The West Jerome Property focuses in the copper-rich district of Arizona, close to the Town of Jerome, Central Arizona. The West Jerome property comprises roughly five square kilometers of claims on the west side of Freeport McMoran patented lands.

A Volcanogenic Sulfide camp, the Property is a high-grade, massive sulfide target positioned 2.4 km south of the past-producing United Verde Mine. Cornerstone Metals retains a 100 percent interest in the Project.

Last week, Cornerstone Metals announced additional preliminary results of metallurgical test work taking place on its Carlin Vanadium Project in Nevada. The third round of testing has attained vanadium extraction levels of 95.5 percent. Test work continues on a sample composite generated from an 18.9 meter drill core intercept from Cornerstone’s recent diamond drilling verification program on the deposit.

Cornerstone Metals, Inc. (CCCCF), closed Wednesday's trading session at $1.0091, up 3.39%, on 41,073 volume with 48 trades. The average volume for the last 60 days is 65,518 and the stock's 52-week low/high is $0.0512/$1.41.


ForeverGreen Worldwide Corporation (FVRG)

OTC Markets, InvestorsHub, 4-Traders, MarketWatch, and MicroCapDaily reported on ForeverGreen Worldwide Corporation (FVRG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ForeverGreen Worldwide Corporation is a global direct marketing company and provider of health and wellness products. It develops, manufactures, and distributes a wide-ranging line of all-natural whole foods and products to North America, Australia, Europe, Asia, and South America. ForeverGreen Worldwide’s shares trade on the OTC Markets Group’s OTCQB. The Company is based in Lindon, Utah.

ForeverGreen Worldwide products include its new global Xpress offering Prodigy-5™, featuring the exclusive TransArmor™ Nutrient Technology. Moreover, its products include PowerStrips™, SolarStrips™, with industry exclusive marine phytoplankton and BeautyStrips™.

In addition, the Company offers the North American market its weight-management line named Ketopia™, and also additional weight management products. ForeverGreen Worldwide also offers its Pulse-8™ powered L-arginine formula for cardiovascular health.

ForeverGreen Worldwide has its new wearable technology named CareWear™. CareWear, in combination with the daily use of ForeverGreen nutritional products, is what the Company is positioning as the Total Health Experience, which completes the outside edge of nature, science, products, education and technology formulated in research and development (R&D) of all ForeverGreen’s product offerings.

The above-mentioned TransAmor™ Nutrient Technology is patent pending. It was created from four decades of peer-reviewed science. TransAmor™ Nutrient Technology allows the nutrients in formulated products to be substantially better absorbed by the body.

ForeverGreen Worldwide’s Prodigy-5 is an all-in-one nutritional shot. It features the patent-pending and exclusive TransArmor™ Nutrient Technology for increased absorption. Prodigy-5 provides vitamins, minerals, antioxidants and energy, all in one.

Recently, ForeverGreen™ Worldwide announced it moved its European logistics support to France to improve efficiencies. The Company stated that these changes of logistic operations will reduce shipping costs and provide improved marketing support.

The new company includes a marketing arm, which will help it increase membership and market in the European regions. This will help the European leaders and members with marketing systems that should lead to this increased member growth.

ForeverGreen Worldwide Corporation (FVRG), closed Wednesday's trading session at $0.143, down 24.74%, on 16,166 volume with 3 trades. The average volume for the last 60 days is 14,519 and the stock's 52-week low/high is $0.0251/$0.39.


Noble Roman's, Inc. (NROM)

FeedBlitz,, The Bowser Report, StockOodles, Wall Street Resources, TaglichBrothers, and SmallCapVoice reported on Noble Roman's, Inc. (NROM), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. The Company’s business model comprises three growth venues. These are Grocery Take-n-Bake Licensing; Non-Traditional Franchising; and Stand-Alone Franchising. The Company franchises and licenses under the Noble Roman’s Pizza, Noble Roman’s Take-N-Bake, Tuscano’s Italian Style Subs, and Noble Roman's Craft Pizza & Pub trade names. Noble Roman's is based in Indianapolis, Indiana.

The Company opened its first location in February 2017 for its new-generation, stand-alone pizzeria concept named “Noble Roman's Craft Pizza & Pub”. The initial location opened in 4,000 square feet of the newly constructed Monon Marketplace on Main Street/Highway 32 across from Grand Park in Westfield, Indiana.

Noble Roman’s Craft Pizza & Pub features two styles of hand-crafted, made-from-scratch pizzas with a selection of 40 different toppings, cheeses, and sauces. In addition, beer and wine is featured, with 16 different beers on tap.

Noble Roman's has awarded franchise and/or license agreements in all 50 U.S. States plus Washington, D.C. Moreover, it has awarded franchise and/or license agreements in Puerto Rico, the Bahamas, Italy, Canada, and the Dominican Republic.

Concerning Non-Traditional Venues, these are typically located in a host facility whose primary business is other than foodservice. These facilities can add pizza-focused foodservice as a Revenue Center; as a Facility Draw; and as an Employee Benefit. Example kinds of locations include Bowling Centers; Convenience Stores; Walmart®/Retail Centers; Hospitals; Entertainment Facilities; and Military Bases.

Regarding Stand-Alone Venues, these are traditional pizzeria locations and Take-n-Bake locations. There is a merging over time between the types of Stand-Alone Venues: Live Yeast Dough; Hand-Rolled Breadsticks; and Baking Services.

Grocery Take-n-Bake Licensing involves licensing of individual Groceries to sell
Noble Roman’s Pizza. This is a component program using Noble Roman’s ingredients, in which delis assemble pizzas from standard Noble Roman’s ingredients.

Last week, Noble Roman's announced highlights from the most recent three-month and nine-month periods ended September 30, 2017. For the three-month period ended September 30, 2017, versus the comparable period ended in 2016; Total Revenue was $2.5 million versus $2.0 million. This represents a 24.3 percent increase. Operating Income was $761,000 versus $856,000. Net Loss was $1.2 million, or $.06 per basic share, versus a Net Loss of $993,000, or $.05 per basic share.

The first unit of Noble Roman's Craft Pizza & Pub (CPP) concept continues to surpass Company Management's pre-opening expectations. For the eight months that the unit has been open (February through September), Sales were $1.22 million net of discounts and promotions, with a Net Income of $321,000.

Noble Roman's reiterated that the second CPP location was on schedule to open on November 17, 2017.  The third CPP is scheduled to open mid-January, 2018. The Company is also considering an array of locations for its fourth location to open in early spring 2018.

Noble Roman's, Inc. (NROM), closed Wednesday's trading session at $0.668, up 7.74%, on 1,500 volume with 1 trade. The average volume for the last 60 days is 21,559 and the stock's 52-week low/high is $0.38/$0.87.


ARC Group, Inc. (ARCK)

Zacks, OTC Markets, InvestorsHub, MarketWatch, Stockhouse, YCharts, Capital Cube, Barchart, Insider Monkey, GuruFocus, 4-Traders, and The Street reported on ARC Group, Inc. (ARCK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Established in 2000, ARC Group, Inc. is the owner, operator, and franchisor of the Dick’s Wings & Grill concept. Dick’s Wings has 15 restaurants in Florida and five restaurants in Georgia. Dick's Wings is actively offering franchise opportunities in Florida, Georgia, Alabama, Louisiana, North Carolina and South Carolina. Dick’s Wings & Grill® restaurants provides its customers a casual, family-fun restaurant environment designed to appeal to families and sports fans alike.

ARC Group has its head office in Jacksonville, Florida. Its shares trade on the OTC Markets’ OTCQB.

Dick’s Wings features its award-winning chicken wings, hog wings, and duck wings spun in its signature sauces and seasonings. In addition, it offers its own proprietary line of craft beers under the name “Dick’s Craft Beers”.

Dick's Wings offers an assortment of boldly-flavored menu items. These are highlighted by its award-winning, Buffalo, New York-style chicken wings and hog wings and its Dick's Blingz® boneless chicken wings in 365 flavors.

Furthermore, Dick’s Wings offers customers a variety of fresh sandwiches, burgers, wraps, salads, and signature waffle fries. The restaurants are an elevated sports-themed environment. They include flat screen TVs positioned throughout each facility and children's areas filled with video games and other kinds of children's entertainment.

Dick’s Wings has two concession stands at TIAA Bank Field (previously EverBank Field), home of the NFL's Jacksonville Jaguars. It also has a concession stand at Jacksonville Veterans Memorial Arena, home of the National Arena League's Jacksonville Sharks.

Last month, ARC Group announced financial results for Q1 2018 highlighted by record Revenue. The Company’s Revenue increased 14 percent to $1,246,662 for Q1 2018 from $1,088,796 for Q1 2017.

Net Income was $47,614 or $0.01 per share during Q1 2018 versus 206,077 or $0.03 per share during Q1 2017.

Mr. Richard W. Akam, ARC Group’s Chief Executive Officer, stated, "Our Q1 2018 results show continued strength in our business. We expect to open additional Dick's Wings restaurants during the remainder of 2018, an[d] are currently evaluating potential acquisitions of multiple leading restaurants brands.”

This month, ARC Group announced that it intends to acquire the Tilted Kilt Pub and Eatery franchise. SDA Holdings, LLC, a company owned by Mr. Fred W. Alexander, a member of the Board of Directors of ARC Group, and the owners of Tilted Kilt have completely executed all of the agreements for the sale of Tilted Kilt to SDA Holdings.

SDA Holdings is using funds loaned to it by Seenu G. Kasturi, ARC Group's Chairman and Chief Financial Officer, to satisfy its payment obligations under the agreements for the explicit purpose of holding the franchise until such time as ARC Group has attained suitable financing to acquire the franchise.

ARC Group, Inc. (ARCK), closed Wednesday's trading session at $1.85, even for the day, on 2,000 volume with 2 trades. The average volume for the last 60 days is 1,456 and the stock's 52-week low/high is $0.8178/$2.25.


Freedom Holding Corp. (FRHC)

Stockflare, OTC Markets, Marketbeat, Stockopedia, Stockwatch, Investors Hangout, Barchart, Wallet Investor, Simply Wall St, Stockhouse, Last10K, 4-Traders, InvestorsHub, MarketWatch, Insider Monkey, and The Stock Market Watch reported on Freedom Holding Corp. (FRHC), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Freedom Holding Corp. conducts retail financial brokerage, investment counseling, securities trading, investment banking and underwriting services via its subsidiaries under the name of Freedom Finance in the Commonwealth of Independent States (CIS). A financial services holding company, Freedom Holding has its corporate office in Almaty, Kazakhstan. The Company has executive office locations in the United States and Russia.

Freedom Holding employs greater than 400 experienced professionals throughout branch offices in Kazakhstan, Russia, Kyrgyzstan, Ukraine and Cyprus.

This past April, Freedom Holding announced the opening of its first branch office of Freedom Finance in Tashkent, Uzbekistan. This office will be situated in the city's International Business Center. The office will initially employ 12 investment consultants.

Last month, Freedom Holding announced that its subsidiary Freedom Finance JSC successfully completed the acquisition of Asyl-Invest JSC. The equity capital of Freedom Finance after the transaction exceeds KZT 17.5 billion.

The acquisition joins the two largest retail brokerage firms in Kazakhstan serving over 50,000 client accounts. Freedom Finance JSC is the largest retail brokerage firm in the Republic of Kazakhstan.

This acquisition provides thousands of new investors with access to Freedom Finance's TRADERNET trading platform. The acquisition also provides investors with access to fourteen branch offices across Kazakhstan and greater than 223 employees working as customer consultants, securities analysts and traders in Kazakhstan.

Earlier this month, Freedom Holding announced that its subsidiary LLC IC Freedom Finance (Moscow, Russia based) completed the acquisition of Nettrader Brokerage Company. LLC IC Freedom Finance is currently, in terms of the number of its registered clients, the 8th largest retail securities broker in Russia. This is according to data published by the Moscow Exchange.

This acquisition adds roughly 16,000 clients across Russia to the LLC IC Freedom Finance client base. Moreover, LLC IC Freedom Finance expands its investment technology assets with the acquisition of Nettrader Brokerage Company.

Freedom Holding Corp. (FRHC), closed Wednesday's trading session at $7.85, up 2.61%, on 1,494 volume with 8 trades. The average volume for the last 60 days is 6,210 and the stock's 52-week low/high is $0.2475/$8.03.


NightFood Holdings, Inc. (NGTF)

Equities, Barchart, MarketWatch, and Innovative Marketing reported on NightFood Holdings, Inc. (NGTF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

NightFood Holdings, Inc. is a snack company headquartered in Tarrytown, New York. The Company’s devotion is to provide consumers delicious, “better-for-you” choices for evening snacking. NightFood creates, manufactures, and distributes products to help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly manner. Incorporated on October 16, 2013, NightFood Holdings lists on the OTC Markets Group’s OTCQB.

NightFood has its Midnight Chocolate Crunch Bar and its NightFood-Cookies n’ Dreams Bar in its present product lineup. NightFood is working to add more offerings to its line of “better-for-you” nighttime snacks.

The Company is exploring product development and major distribution opportunities in other popular snack formats such as ice cream and "bites." Furthermore, gluten-free versions of NightFood products are currently undergoing development.

NightFood Holdings is building a Scientific Advisory Panel to provide continuing expertise and guidance regarding new product development and formulations. This announcement came in response to research presented in June at SLEEP 2017, the 31st Annual Meeting of the Associated Professional Sleep Societies LLC, and published in major media outlets around the world.

The study was funded by the National Institutes of Health. It was conducted by researchers at the Perelman School of Medicine at the University of Pennsylvania. The study explored the influence of eating at night on sleep quality and overall health.

Last week, NightFood Holdings announced that venture capitalist and bio-technology consultant, Mr. Jeffrey Robinson, has been engaged by the Company to evaluate applications of CBD within the nighttime snack space and other related areas of opportunity. Mr. Robinson is Managing Director of MJ Accelerator, which is a wholly-owned division of Player's Network, a diversified holding company. He is also Chief Executive Officer at Internet Bull Report.

NightFood is now evaluating opportunities to introduce snacks with cannabidiol (CBD), strains of which are broadly accepted to promote better sleep. The Company is exploring the CBD space with guidance from Company Advisory Board member Dr. Michael Grandner, Director of the Sleep and Health Research Program at the University of Arizona.

In addition, last week, Player’s Network, Inc. (PNTV), a diversified holding company operating in media and marijuana, announced a strategic partnership and Development Agreement with NightFood Holding to develop a CBD infused line of nighttime snacks.

Green Leaf Farms Holdings is a subsidiary of PNTV. Green Leaf is working with Mr. Robinson and NightFood to commence developing a line of CBD-infused nighttime edibles. Green Leaf will be responsible for the cultivation and extraction of the CBD oils to infuse into the new line of products. These products would be formulated to support and promote better sleep.

NightFood Holdings, Inc. (NGTF), closed Wednesday's trading session at $0.39, up 0.65%, on 228,539 volume with 83 trades. The average volume for the last 60 days is 269,273 and the stock's 52-week low/high is $0.056/$0.695.


Intelligent Cloud Resources, Inc. (ITLL)

Business Wire, 4-Traders, and Market Exclusive reported earlier on Intelligent Cloud Resources, Inc. (ITLL), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Intelligent Cloud Resources, Inc. has been working to provide cloud enabler and cloud broker services to small and medium sized organizations in Canada. In addition, the Company’s plan is to expand to such organizations in the United States. The Company’s shares trade on the OTCQB.

This past August, Intelligent Cloud Resources announced the expansion of its North American operations with the opening of new corporate offices and technology center. The Company’s new offices are located in Oakville, Ontario. These offices provide more than 12,000 square feet.

Mr. Christopher Pay, Intelligent Cloud Resources’ Chief Executive Officer, said, "The results of our move is a state-of-the-art facility which provides the space needed to grow, collaborate and innovate, as ITLL continues to break new ground and build the bridge between the Financial Services space and Mobile Consumer Products and Services."

The Company’s Fonia “All Access Mobile” is an end-to-end Mobile solution. Intelligent Cloud Resources said that the launch of the Fonia “All Access Mobile” platform will be a strong consumer oriented addition to its product family.

Fonia "All Access Mobile" works to serve individuals, regardless of their credit score, by way of an MVNO (Mobile Virtual Network Operator) Fonia Mobile (and Fonia Financial). The service will bundle a traditional handset sale with a hybrid phone rate plan (a mix of prepaid and post-paid plans) and a prepaid MasterCard.

Fonia offers phones and plans with its Fonia “All Access Mobile”. Furthermore, all subscribers receive a premium MasterCard. A user of Fonia can obtain another 30-day no-contract plan, and also save time with Auto-Refill.

Intelligent Cloud Resources shares networks with the four leading carriers. A customer can activate with a new number. Additionally, a customer can activate and transfer their number.

Intelligent Cloud Resources announced earlier in 2017 that it has an agreement to obtain a perpetual license to provide Leagoo Smart Phones and the inventive Fonia "All Access Mobile" platform to the territory of Florida.

In July of 2017, the Company announced the successful completion of the previously announced acquisition of the unique Fonia “All Access Mobile” platform perpetual license and first-rate Leagoo Smart Phones for the territory of Florida. This will be the first step in a program to launch the product and service in manifold territories.

Intelligent Cloud Resources, Inc. (ITLL), closed Wednesday's trading session at $0.04, up 90.48%, on 12,500 volume with 1 trade. The average volume for the last 60 days is 15,722 and the stock's 52-week low/high is $0.021/$0.99.


Magellan Gold Corp. (MAGE)

Penny Stock Pick Report, Super Hot Penny Stocks, Super Nova Stock Picks, Penny Stock Pick Alert, RisingPennyStocks, Pumps and Dumps, SixFigureStockPicks, Greenbackers, PennyPickAlerts, PennyStockMoneyTrain, FOX Penny Stocks, Joe Penny Stocks, Liquid Tycoon, WePickPennyStocks, and Winning Penny Stock Picks reported on Magellan Gold Corp. (MAGE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Magellan Gold Corp.’s main business is the acquisition and exploration of mineral resources. The Company involves in the acquisition and exploration of precious metals mineral properties. Its updated strategic objective is building a mid-tier precious metals exploration and mining company. Magellan Gold is based in Vacaville, California. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Magellan Gold’s Silver District" project comprises 94 unpatented lode mining claims, 6 patented lode claims, an Arizona mining lease of 335 acres, and 23 unpatented mill site claims, totaling over 2,000 acres. Magellan holds its properties by way of its 85 percent owned subsidiary Gulf & Western Industries, Inc.

The Company’s district-scale property position covers the core of the historic Silver District in La Paz County, roughly 50 miles north of Yuma. At the Silver District Project in southwest Arizona, Magellan’s aim is to expand its resource base containing an historic resource of 16 million ounces of silver. Additionally, it plans to acquire more advanced-stage properties, which have tangible promise for development.

Magellan Gold has the right to earn an undivided 50 percent interest in the Niñobamba Silver/Gold Project in central Peru. To earn its 50 percent interest, it must spend $2.0 million in exploration over three years. The Niñobamba project encompasses 9,027 acres and demonstrates potential for a large, bulk tonnage, silver-gold deposit.

Regarding the Niñobamba Project, strategic additions to the land package have created a large, contiguous property consisting of 3100 hectares and another 553-hectare concession pending title confirmation. Magellan Gold will be spending US$2 million at the Niñobamba project to earn its 50 percent interest.

Magellan Gold announced in March of this year that it entered into a Memorandum of Understanding (MOU) with Rose Petroleum plc to purchase an operating floatation plant that also includes a precious metals leach circuit and associated assets, licenses and agreements (together, the SDA Mill), located in the State of Nayarit, Mexico, for a total consideration of US$1.5 million.

The basis of the mill's normal operation is on sales of floatation concentrates to smelters, and payment for precious metals content. The mill presently engages in toll milling for third party ore producers. Rose Petroleum is a multi-asset natural resource enterprise.

Effective for the month of November 2017, operations of the SDA Mill have re-started under an interim milling agreement between Magellan Gold and Rose and its Mexican operating subsidiary. At present, the processing plant is treating third-party ore on a toll basis at the rate of 100 tons per day.

Magellan Gold has funded costs of the interim operations under an approved budget. It will be entitled to proceeds from it. Until November 2017, milling activity was on hold pending the completion of the purchase transaction.

Magellan Gold Corp. (MAGE), closed Wednesday's trading session at $0.035, up 14.75%, on 46,755 volume with 9 trades. The average volume for the last 60 days is 20,339 and the stock's 52-week low/high is $0.012/$0.185.


Aurania Resources Ltd. (AUIAF)

Penny Stock Hub, StockCharts, Streetwise Reports, Stockwatch, OTC Markets, Wallet Investor, 4-Traders, MarketWatch, Stockhouse, Barchart, GuruFocus, Morningstar, Investors Hangout, Investing News Alerts, TradingView, and Junior Mining Network reported on Aurania Resources Ltd. (AUIAF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Aurania Resources Ltd. is a junior exploration mining company listed on the OTC Markets Group’s OTCQB. The Company engages in the identification, evaluation, acquisition and exploration of mineral property interests. Its emphasis is on precious metals and copper. Aurania Resources has its corporate office in Toronto, Ontario.

The Company’s flagship asset is The Lost Cities-Cutucu Project. It is situated in the Jurassic Metallogenic Belt in the eastern foothills of the Andes mountain range of southeastern Ecuador. The Lost City Project is in the south-eastern part of the Republic of Ecuador, in the Province of Morona-Santiago.

The Project consists of circa 208,000 hectares in 42 concessions occupying the central part of the Cordillera de Cutucu.  The concessions extend about 95 km along the Cordillera.

Furthermore, Aurania has three projects in Canton Valais, Switzerland. These are Siviez (Uranium, Copper and Gold), Marécottes (Uranium), and Mont Chemin (Gold). All of these projects are 100 percent held via the Company’s wholly-owned subsidiary AuroVallis SARL.

At the end of May, Aurania Resources reported the discovery of a new epithermal zone approximately eight kilometers south of the "Crunchy Hill" region. This new discovery is called "Yawi".

Furthermore, two diatremes (breccia bodies) were found in close by outcrop. The Company states that presumably there is a geological connection between the diatremes and the mineralization.

Rocks in the area are clay-and sericite-altered.  Preliminary XRF (x-ray fluorescence) analysis indicates anomalously high levels of mercury and arsenic in selected samples. These are natural pathfinder elements for precious metals. They can be used to vector in to the mineralization.

Aurania's Chairman and Chief Executive Officer, Dr. Keith Barron, said, “The samples from Yawi that have been collected to date have the most impressive epithermal textures I have seen in my career, and the Latorre area contains anomalous levels of arsenic, antimony, mercury, selenium, thallium and silver.”

Aurania Resources Ltd. (AUIAF), closed Wednesday's trading session at $1.6507, down 5.36%, on 12,358 volume with 34 trades. The average volume for the last 60 days is 10,246 and the stock's 52-week low/high is $1.025/$6.0633.


BAB, Inc. (BABB)

SmallCapVoice, Zacks, Greenbackers,, and OTC Markets Group reported earlier on BAB, Inc. (BABB), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

BAB, Inc. franchises and licenses Big Apple Bagels®, My Favorite Muffin®, SweetDuet® frozen yogurt, and Brewsters’® Coffee. Additionally, the Company engages in the sale of bagels, muffins, and coffee via nontraditional channels of distribution, including under licensing agreements. BAB Systems, Inc. is the Company’s franchising subsidiary. BAB is based in Deerfield, Illinois. The Company lists on the OTCQB.

BAB acquires its revenues mainly from the ongoing royalties paid to it by its franchisees as well as receipt of initial franchise fees. Moreover, the Company receives revenue from the sale of licensed products (My Favorite Muffin mix, Big Apple Bagels cream cheese, Big Apple Bagels frozen bagels, and Brewster's coffee).

Royalty fees represent a 5 percent fee on net retail and wholesale sales of franchised units. BAB earns a licensing fee from the sale of BAB branded products from a third-party commercial bakery, to the franchised and licensed units. Bab’s nontraditional channels of distribution are Kohr Bros. and Green Beans Coffee.

Furthermore, included in licensing fees and other income is Operation's Sign Shop revenue. The Sign Shop provides the bulk of signage. This includes but is not limited to, posters, menu panels, outside window stickers, and counter signs to franchisees to provide consistency and convenience.

The Company’s Big Apple Bagels is a national chain of fast-casual restaurants. BAB’s My Favorite Muffin is a national chain of fast-casual restaurants with hand-crafted products. BAB’s SweetDuet® is a Duet Yourself® frozen yogurt bar. It includes a complete offering of gourmet muffins.

BAB’s Brewsters' Coffee® hand picks only the top 2-3 percent of Arabica beans from around the world. Brewsters’ hand roasts its beans in small batches. In addition, BAB’s has Jacobs Bros. Bagels (frozen raw dough and par-baked varieties).

In October, BAB announced its financial results for Q3 ended August 31, 2017. The Company had Revenues of $564,000 and Net Income of $132,000, or $0.02 per share. This is in comparison to Revenues of $616,000 and Net Income of $165,000, or $0.02 per share, for the same quarter the year prior.

For the nine months ended August 31, 2017, BAB had Revenues of $1,664,000 and Net Income of $321,000, or $0.04 per share. This is in comparison to Revenues of $1,761,000 and Net Income of $386,000, or $0.05 per share for the same period last year.

BAB, Inc. (BABB), closed Wednesday's trading session at $0.70, up 1.29%, on 2,263 volume with 4 trades. The average volume for the last 60 days is 2,420 and the stock's 52-week low/high is $0.61/$0.82.


The QualityStocks Company Corner

Zenosense, Inc. (OTC: ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO).

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Zenosense (OTC:ZENO), a client of NNW and healthcare technology developer focused on transformational, disruptive medical diagnostic projects. To view the full publication, titled “Diagnostics Play Critical Role in Medical Sector,” visit:

Zenosense, Inc. (OTC: ZENO) (the “Company”) is a healthcare technology developer that participates in transformational, disruptive medical diagnostic projects; particularly handheld devices used at the Point of Care which are displacing slow and expensive laboratory tests.

Zenosense is primarily focused on the development and commercialization of MIDS Cardiac™ through the Company’s joint venture ownership in MIDS Medical Limited (“MML”). MIDS Cardiac is in development as a cost-effective, handheld Point of Care (“POC”) diagnostic device and disposable test strip for the early, rapid detection of suspected acute myocardial infarction (“AMI”, or “heart attack”).

Identification of very low levels of cardiac markers can significantly accelerate critical triage, diagnosis, treatment and disposition of patients reporting chest pain. Cardiac troponin is well documented as the preferred biomarker for diagnosis of AMI, with evidence continuing to demonstrate that high sensitivity troponin is the most powerful prognostic biomarker for the assessment of cardiovascular risk in the general population. However, highly sensitive troponin assays are currently available only on state of the art, central laboratory analyzers. These analyzers are extremely expensive, not generally available at the POC and slow to turnaround results (typically 60 minutes) when time is critical.

True, high-sensitivity devices are not available in smaller handheld devices at the POC, where they are most needed. This is because the optical detection systems generally used in central laboratory analyzers cannot be effectively miniaturized.

MIDS Cardiac uses the patented MIDS technology platform, exclusively available to MML. Instead of using conventional optical detection, MIDS can detect and quantify assay beads nano-magnetically. This means it can be incorporated in a small device expected to achieve highly sensitive detection levels, which can support true high sensitivity cardiac biomarker tests in emergency settings, at the POC.

Harnessing world-class expertise, the MML laboratory is located at the prestigious Sci-Tech Daresbury campus in the U.K., internationally recognized for leading-edge, scientific research and commercial development. MML has the sole rights to the MIDS technology platform, which is protected by patent applications already granted in China and the USA, and applications now in the national phase in all other key geographic areas.

MIDS Cardiac aims to provide a single troponin I or T test within 3 minutes and three panel assay (additional cardiac biomarkers) on a disposable test strip within 8 minutes, using a hand-held device costing a fraction of the price of laboratory analyzers.

MIDS Cardiac should only require a pin prick of blood for a single assay test carried out on an easy-to-use, disposable microfluidic test strip. MIDS Cardiac is being designed to be operated quickly by minimally trained personnel, producing a simple to interpret result in emergency settings, even in the back of an ambulance.

Initial testing of the electronic and microfluidic components of the MIDS Cardiac “Hybrid Strip” system was completed in November 2017. The Hybrid Strip system used for development testing aims to replicate as closely as possible a fully integrated Lab on Chip MIDS test strip set-up. Development testing was conducted on both the assembled hybrid unit and its electronic and microfluidic components separately, focusing mainly on the electronics of the magnetic sensing system.

Testing revealed that a variety of brands and sizes of commercially available assay beads could be magnetically detected in very low quantities, including samples of beads that were previously undetectable. In several instances, the current “limit of detection” appeared to already be at or near to the range advised by MML’s assay consultants as suitable for a high sensitivity troponin assay.

Dr. Nasser Djennati, MML’s Managing Director and Chief Scientific Officer, said; “These results come in at the very high end of detection expectations, even at this Hybrid Strip stage. As we move forward into true Lab on Chip construction, I expect detection levels to improve further still.”

Cardiovascular disease is the leading cause of death in the western world, accounting for more than 17 million deaths in Europe and the United States alone. Nearly 20 million patients each year visit an emergency room with reports of chest pain, with hundreds of millions spent on unnecessary admissions to the hospital. Zenosense Inc. is confident MIDS Cardiac will deliver unparalleled levels of accuracy, speed, reliability, ease of use and cost savings, making it the future device of choice for hospitals, emergency rooms, medical practitioners, paramedics and in low-resource settings.

The MIDS technology is also seen as having a far wider application, with the platform being capable of performing Point of Care immunoassay tests for a vast array of common healthcare concerns, a market projected to be worth $23.7 billion per year worldwide by 2019. The medical testing market as a whole is projected to be worth $53.34 billion by 2021. Zenosense believes the MIDS technology could be the most significant advance in diagnostic testing services in decades.

Zenosense, Inc. (ZENO), closed the day's trading session at $0.43, up 8.72%, on 544,756 volume with 161 trades. The average volume for the last 60 days is 254,501 and the stock's 52-week low/high is $0.15/$0.895.

Recent News


FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that following higher than anticipated demand the Company has increased the size of its previously announced non-brokered private placement financing. Also today, CannabisNewsWire released a report on the company detailing how FNNZF operates an attractive royalty model that is beneficial for operators and the company. To view the full article, visit:

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.205, off by 1.44%, on 212,990 volume with 105 trades. The average volume for the last 60 days is 32,425 and the stock's 52-week low/high is $0.10/$0.8736.

Recent News



The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (OTC:NUGL) (the “Company”), the cannabis industry's new standard of technology, today announces the release of its Apple and Android apps in Google Play and iTunes Stores.

NUGL Inc. (OTC: NUGL), is a search engine and online directory for the marijuana industry. NUGL’s database includes listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands. The company focuses on leading the evolution in business relations, development and organic data in the cannabis industry with metasearch technology.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.06, up 0.95%, on 66,553 volume with 67 trades. The average volume for the last 60 days is 98,884 and the stock's 52-week low/high is $0.405/$1.80.

Recent News


Pivot Pharmaceuticals Inc. (OTCQB: PVOTF)

The QualityStocks Daily Newsletter would like to spotlight Pivot Pharmaceuticals Inc. (PVOTF).

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it will file an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) and Clinical Trial Application (CTA) with Health Canada to begin human clinical trials of PVT-005, the Company's pharmaceutical drug candidate for the treatment of Female Hypoactive Sexual Desire Disorder (HSDD).

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism.

Research into the bioavailability of cannabinoid-based therapeutics shows that rates of absorption vary greatly between smoking cannabis to an orally-consumed product, with a difference noted even between individuals. Cannabinoids are degraded in the stomach and smoking may not appeal to patients for health or lifestyle reasons. Topical delivery, while a better alternative, has suffered from weak formulation issues. Transdermal cannabinoid delivery, on the other hand, could provide a better alternative route since it reduces side effects and bypasses other absorption issues. In addition, transdermal delivery provides the benefit of enabling patients to access a steady stream of medication over a prolonged period with fewer side effects.

Pivot Pharmaceutical’s newly created subsidiary, Pivot Green Stream Health Solutions Inc. (“Pivot Green Stream”), will focus on improving the bioavailability of cannabinoid-based and pharmaceuticals. BiPhasix™ has been tested in FDA and EMA approved human clinical trials, which have shown the delivery system enhances the bioavailability of many drugs and improves clinical outcomes. Pivot Green Stream is tasked with developing several natural health products containing cannabinoids (CBD) that can receive a Health Canada Natural Health Product (NHP) designation. This marketing method ensures a shorter development cycle and faster revenue generation opportunities.

Pivot Pharmaceuticals Inc., which has positioned itself as a growing and crucial vertical in the cannabis industry, represents a compelling opportunity in the biotechnology field. The company’s plans include working with Licensed Producers (LP) and Licensed Dealers (LD) to bring newer therapies to patients. The company has also applied to list on the Canadian Stock Exchange (CSE).

The global medical marijuana market is expected to reach a value of $55.8 billion by 2025, according to a new report by Grand View Research, Inc. The growing number of states and countries gaining approval for using cannabis in therapeutic applications is expected to continue driving the market forward.

Pivot Pharmaceuticals has assembled a highly experienced management team, bringing together a wealth of clinical, commercial, product development and financial experience. Among the many healthcare targets in Pivot’s pipeline are cancer supportive care, pain and inflammation, women’s sexual dysfunction, dermatology and eye disease.

Pivot Pharmaceuticals Inc. (PVOTF), closed the day's trading session at $0.339, off by 0.29%, on 77,025 volume with 32 trades. The average volume for the last 60 days is 135,836 and the stock's 52-week low/high is $0.047/$2.46.

Recent News


Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Choom Holdings Inc. (CSE:CHOO) (CNSX:CHOO) (CHOO.CN) (OTCQB:CHOOF), formed with the sole intent of creating a recreational brand for Canada, and recent corporate developments including a strategic investment by Aurora Cannabis Inc.

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.929, up 3.22%, on 786,743 volume with 545 trades. The average volume for the last 60 days is 544,210 and the stock's 52-week low/high is $0.18/$1.10.

Recent News


Marijuana Company of America Inc. (OTC: MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Tucked into the 2018 Farm BIll of more than 1,000 pages is hemp legalization legislation supported by Senate Majority Leader Mitch McConnell. Through its hempSMART™ subsidiary, Marijuana Company of America, Inc. (OTC: MCOA) is a shining example of one of only a few companies currently providing consumers hemp plant-based products under the rubric of existing laws, and the company has undertaken broad-based legal hemp cultivation programs.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0417, off by 2.57%, on 6,090,614 volume with 327 trades. The average volume for the last 60 days is 6,962,145 and the stock's 52-week low/high is $0.0195/$0.0728.

Recent News


Earth Science Tech, Inc. (OTC: ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTC: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, as well as research and development, signs agreement to work collectively with AATAC to present the “ETST” product line to their vast network of approximately 90,000 retail outlets throughout the U.S. Also Today, Earth Science Tech, through its Earth Science Pharmaceutical subsidiary, announced that the company is finalizing plans to launch global marketing and sales of its MSN-2 home testing medical kit for the detection of sexually transmitted infections (STI) in women. ETST plans to market it in such far-flung countries as Vietnam and Morocco (

Earth Science Tech, Inc. (OTC: ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.78, off by 1.89%, on 13,170 volume with 20 trades. The average volume for the last 60 days is 12,982 and the stock's 52-week low/high is $0.324/$1.62.

Recent News


American Helium (TSX.V: AHE) (OTC: AHELF)

The QualityStocks Daily Newsletter would like to spotlight American Helium (AHELF).

American Helium (TSX.V: AHE) (OTC: AHELF) is positioned to bridge the helium supply gap with its estimated 7.85 billion square feet of helium reserves in Utah. To view the full article, visit:

American Helium (TSX.V: AHE) (OTC: AHELF) is a resource exploration company focused on the global growth of technology-driven demand for helium and the development of high grade helium resources in North America. Through such activities, it strives to contribute to the global helium inventory and become an industry leading producer.

The Canadian helium exploration and development company is led by an experienced management and technical team. The Company is currently focused on three properties in prolific areas for Helium exploration.

Recently, the company executed an agreement with Holbrook Basin Energy LLC of Golden, CO to undertake an exploration drill program in Arizona. The Arizona project location is in the “Four Corners” area where the States of Utah, Colorado, New Mexico and Arizona meet, and in the helium productive Holbrook Basin, a well-established helium production district where concentrations of the gas are as high as 10%. The area has good potential for additional discovery and production. The abundant nature of the region has led to anecdotal statements over the years that “Arizona is the Saudi Arabia of helium.”

The Company holds 100 percent working interest and 87.5 percent net revenue interest in 12 federal leases at its Bruin Point property spanning across 17,000 acres in the Greater Uintah Basin, Carbon County, Utah (the Carbon County project). American Helium is undertaking preparations for the drilling of an exploration well, and as part of that process a Notice of Staking (NOS) has been filed with the offices of the Bureau of Land Management (BLM).

Evaluation is currently ongoing to determine potential additional acquisitions in regions that are known for their helium production. The Company is planning exploration wells with the prospect of capturing new resources and improving the Company’s market position during the year.

The Company has also executed a project agreement with Yankee Resources LLC of Golden, CO and has appointed LoneTree Energy & Associates LLC to acquire certain acreage in SE Colorado. The project consists of two parts. The first objective is to re-drill two wells that have proven helium resources. Both were plugged and abandoned in the mid-nineties, offering the potential for near term production. The second part of the project will offer an exploration focus through the acquisition of land and a subsequent 3D seismic survey aimed at further defining areas of likely helium accumulations.

The company set up a Denver satellite office aimed at overseeing the regional operations in Utah better and at facilitating expansion in SE Colorado. Company President and CEO Frank Jacobs, a petroleum engineer with 35+ years of operational experience, will oversee U.S.-based operations.

Global helium demand is driven by a number of different industries. Primarily, the military, healthcare, nuclear, aviation and electronics. A colorless, odorless and non-toxic gas, helium is lighter than air and it has the lowest boiling point of all elements. This property makes it essential for a wide variety of tech based applications.

The U.S. ranks as the largest producer and consumer of helium. North America accounts for approximately a third of the world’s helium consumption (2.6 billion cubic feet of helium per year). The world’s annual consumption of helium is set at eight billion cubic feet per year. As far as production goes, the U.S. is responsible for 55 percent of the global helium supply. Qatar, Algeria and Russia come next.

The fact that production efforts have been centralized and focused in just a few countries has long been a source of industry concern. “The concentration of production among a handful of countries will continue to be the leading driver of uncertainty of helium supply and price volatility. We are working to identify, explore and place into production helium assets. With the right assets and the necessary funding we are confident we can achieve this objective ,” Frank Jacobs said.

The price of helium has doubled since 2010 because this unique gas cannot be substituted in its applications. In addition, a Qatar production blockage has had a massive negative impact on the helium supply. In the summer of 2017, Qatar’s RasGas closed down both of its plants, responsible for approximately 32 percent of the global helium demand. This shift has contributed to highly favorable supply and demand fundamentals for the remaining market players.

Experts predict that the demand for the gas will continue to grow in the years to come. The global helium market set to exceed $1.5 billion by 2020, advancing at a compound annual growth rate of 9 percent, according to Technavio analysts. Over 20 percent of the global helium demand is for healthcare applications. MRI machines are being installed in hospitals more frequently than ever before, potentially increasing the demand for helium in the medical industry. Innovative aerospace projects and technical applications are also expected to elevate the helium market forecasts in the years to come. Large corporations such as Google and Netflix have both been buying up significant amounts of helium, as the gas can increase the storage capacity of hard drives while also bringing down power consumption.

Additional information about the American Helium research and exploration activities will become available in the months to come. The company is positioning itself to capture the numerous opportunities stemming from increasing helium prices and the growing global demand.

American Helium (AHELF), closed the day's trading session at $0.2604, off by 12.29%, on 13,730 volume with 13 trades. The average volume for the last 60 days is 17,145 and the stock's 52-week low/high is $0.2583/$0.77.

Recent News


First Cobalt Corp. (TSX-V: FCC) (OTCQX: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

First Cobalt Corp. (TSX-V: FCC; ASX: FCC; OTCQX: FTSSF) (the "Company") is pleased to announce the nominees listed in the management information circular dated May 25, 2018 were elected as directors of First Cobalt. Detailed results of the vote for the election of directors held at the annual and special shareholders meeting June 26, 2018 are set out below. meeting on June 26, 2018.

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.34, off by 6.85%, on 355,104 volume with 130 trades. The average volume for the last 60 days is 174,254 and the stock's 52-week low/high is $0.3562/$1.3041.

Recent News



The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

While cannabis merchants and distributors have been sweating the deadline, leading cannabis testing provider EVIO Inc. (OTCQB: EVIO) has been as cool as a cucumber, having prepared for months for the impending changes and to accommodate the increased demand for cannabis testing services that’s sure to accompany them (

EVIO, Inc. (OTCQB: EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed the day's trading session at $1.07, off by 6.96%, on 271,983 volume with 199 trades. The average volume for the last 60 days is 95,996 and the stock's 52-week low/high is $0.47/$2.70.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (TSX: TGOD).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTCQX:TGODF) is pleased to announce it has signed a letter of intent (“LOI”) for a 50/50 joint venture (“JV”) with Queen Genetics/Knud Jepsen A/S (“Knud Jepsen”) based in Hinnerup, Denmark. The JV will initially consist of 200,000 sq. ft. located within Knud Jepsen’s  1.3 million sq. ft. state-of-the-art automated greenhouses in Denmark.

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (TSX: TGOD), closed the day's trading session at $6.01, off by 7.96%, 1,020,000 volume. The stock's 52-week low/high is $2.784/$3.525.

Recent News


Virtual Crypto Technologies Inc. (OTCQB: VRCP)

The QualityStocks Daily Newsletter would like to spotlight Virtual Crypto Technologies Inc. (VRCP).

Virtual Crypto Technologies Inc. (OTCQB: VRCP), an Israel-based technology company whose main goal is to make cryptocurrencies more available to the general public through PCs, tablets, mobile applications, ATMs and other devices, has announced an upgrade to its cryptocurrency point-of-sale terminals. In addition, Virtual Cryptocurrency Technologies has updated its NetoBit application – a real-time algorithmic technology capable of confirming the purchase and sale of cryptocurrency, according to a company press release (

Virtual Crypto Technologies Inc. (OTCQB: VRCP) is a developer of software and hardware for the purchase and sale of cryptocurrencies through ATMs, tablets, PCs and mobile devices. The company’s proprietary algorithmic technology trading platform, called NetoBit Trader, can instantaneously confirm the purchase or sale of Bitcoin, a process that typically can take between 10 minutes to 24 hours. All trades and exchanges are insured up to $3,000 per trade. The global cryptocurrency ATM market is predicted to surpass $285 million by 2025, yet, at present, only 30 percent of these machines allow two-way trades.

With NetoBit Trader, cryptocurrency holders enjoy immediate confirmation of Bitcoin and its crypto equivalents at the best crypto exchange rate at the point of transaction – providing a major breakthrough in the quest to bring cryptocurrencies to the mass market. Virtual Crypto’s cryptocurrency ATM, embedded with currency exchange transaction validation (CETV) in its hardware and software, accepts and dispenses cash and cryptocurrency in seconds.

Virtual Crypto’s NetoBit Trader and mobile retail point-of-sale platform incorporates advanced technologies tailored to the needs of primary market players, users, investors, and business owners. Virtual Crypto’s platform bridges the three main functions of the cryptocurrency sector – exchanges, wallets and payments – to the world of fiat exchanges, granting access to immediate cash exchanges between consumers and businesses worldwide.

NetoBit Trader’s over-the-counter, two-way transaction solution is available through one app, providing online cryptocurrency transactions at ecommerce and gaming portals. The app provides real-time cryptocurrency validation and exchange, easy buying and selling of Bitcoin with cash, enables traders to buy and trade crypto, and gamers to transfer cryptocurrency into cash after play. Crypto users can withdraw funds from their crypto accounts through a NetoBit cryptocurrency ATM or software-enabled tablet, and consumers can purchase retail with crypto from businesses that offer and use the NetoBit software.

The company’s newly redesigned corporate website,, delivers a simple, clean design with enhanced functionality, features and navigation. Virtual Crypto’s new corporate website includes:

  • Downloadable NetoBit Trader app link and contact forms for more information
  • MarketWatch provides real-time tracking of the Bitcoin market, with other currencies to follow
  • Improved security utilizing https certificates to protect personal information and site integrity
  • Media room with downloadable product brochures, corporate presentations and other relevant content
  • Investor’s page provides transparency to investors with direct access to Virtual Crypto’s progress through press releases, SEC filings, senior management team bios, and stock performance charts
  • Social Media integration with buttons for LinkedIn, Twitter and Facebook jump to Virtual Crypto’s social media profiles, providing real-time updates from the online community

“Our primary objective is to make cryptocurrencies accessible to everyone, and that was the motivation for our redesign,” said Alon Dayan, Chief Executive Officer of Virtual Crypto. “The updated content provides real value for our customers, shareholders and employees, showcasing our products and services, in an intuitive, easy to navigate way.”

Virtual Crypto’s strategic vision of “Cryptocurrency Made Easy” allows crypto traders and users to overcome the complex hurdles currently hampering the cryptocurrency sphere.

Virtual Crypto Technologies Inc. (VRCP), closed the day's trading session at $0.1399, off by 11.17%, on 50,429 volume with 10 trades. The average volume for the last 60 days is 36,692 and the stock's 52-week low/high is $0.0125/$0.38.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.